Human GNG8 (Gamma-9) knockout HEK-293T cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
- Sanger seq
Unknown
Sanger Sequencing - Human GNG8 (Gamma-9) knockout HEK-293T cell lysate (AB263222)
Allele-1 : 8 bp deletion in exon2
- Sanger seq
Unknown
Sanger Sequencing - Human GNG8 (Gamma-9) knockout HEK-293T cell lysate (AB263222)
Allele-2 : 1 bp deletion in exon2
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The protein plays a role in the regulation of cell signaling by being part of heterotrimeric G-protein complexes. These complexes mediate signal transduction by activating or inhibiting various downstream effectors leading to changes in cellular responses. GNG8's interactions within the G-protein complex control pathways that affect numerous physiological processes including sensory perception and cardiac function. By altering the output of these signaling pathways GNG8 influences the cellular environment and contributes to maintaining cellular homeostasis.
Pathways
GNG8 participates in key signaling pathways such as the G-protein coupled receptor (GPCR) signaling pathway and the cAMP signaling pathway. In the GPCR signaling pathway GNG8 along with its associated alpha and beta subunits acts as a molecular switch activating or deactivating pathways in response to external stimuli. GNG8's interaction with proteins like GNAI1 a G-protein alpha subunit highlights its role in modulating the cAMP signaling pathway which is involved in energy balance and cell proliferation. Therefore GNG8 contributes to the regulation of these critical pathways.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com